Table 2.
Baseline characteristics
| Control group | T2DM | AMI | |
|---|---|---|---|
| Age (y) | 71.0 ± 6.6 | 70.9 ± 7.3 | 71.3 ± 7.0 |
| Males, n (%) | 81 (56.6%) | 24 (46.2%) | 24 (51.1%) |
| BMI (kg/m2) | 22.5 ± 2.6 | 23.5 ± 2.3** | 22.3 ± 3.0 |
| Hypertension, n (%) | 15 (10.6%) | 9 (17.0%) | 22 (46.8%) |
| ALT (U/L), M (P25,P75) | 20 (17,25) | 23 (19,29)** | 23 (19,31)## |
| AST (U/L), M (P25,P75) | 25 (22,28) | 23 (18,29) ** | 25 (21,30) |
| Total Cholesterol (mmol/L) | 4.31 ± 0.59 | 4.59 ± 1.03* | 4.40 ± 0.90 |
| Triglycerides (mmol/L) | 1.12 ± 0.33 | 2.02 ± 1.29*** | 1.63 ± 0.88### |
| HDL-cholesterol (mmol/L) | 1.30 ± 0.22 | 0.96 ± 0.18*** | 1.00 ± 0.22### |
| LDL-cholesterol (mmol/L) | 2.35 ± 0.46 | 2.37 ± 0.77 | 2.25 ± 0.75 |
| Glucose (mmol/l) | 4.90 ± 0.49 | 7.75 ± 2.95*** | 5.78 ± 1.32### |
| BUN (mmol/L) | 5.50 ± 1.28 | 5.78 ± 3.13 | 6.22 ± 2.82# |
| Uric acid (mmol/L) | 281.3 ± 68.2 | 316.2 ± 96.9* | 366.3 ± 171.7### |
| HCT | 41.6 ± 3.6 | 38.5 ± 5.2*** | 38.8 ± 4.9### |
| WBC (10*9/L) | 6.15 ± 1.60 | 7.30 ± 3.78** | 7.12 ± 2.41# |
| Platelet (10*9/L) | 178.7 ± 49.0 | 180.8 ± 63.0 | 182.0 ± 74.0 |
| Total Protein (g/L) | 71.1 ± 6.0 | 67.4 ± 6.0* | 66.5 ± 6.6## |
| FFAs (mmol/L) | 551.6 (403.0,679.7) | 536.5 (412.6,666.3)*** | 441.0 (298.5,625.0) |
Data are presented as mean ± SD, in a normal distribution of data, or as median (inter quartile range), in a skewed distribution of data.
*P < .05, **P < .01, ***P < .001for the T2DM group vs. the control group.
#P <0.5, ##P < .01, ###P < .001 for the AMI group vs. the control group.